BIOARRAY SL
Company details
- Active NIF/CIF: B54363049
-
-
-
-
Address: Avinguda de la Universitat d'Elx, s/n, 03202 Elx, Alicante, España See in map
-
-
Featured products:
More information on BIOARRAY SL
-
08/01/2020 | BORME act no.: 3803 | Register: ALICANTEDeclaración de unipersonalidad
-
23/11/2017 | BORME act no.: 459464 | Register: ALICANTERevocaciones
-
22/11/2017 | BORME act no.: 457730 | Register: ALICANTECambio de domicilio social
-
29/09/2011 | BORME act no.: 646305 | Register: ALICANTEDepósito de cuentas anuales (Septiembre de 2011)
-
11/10/2010 | BORME act no.: 788509 | Register: ALICANTEDepósito de cuentas anuales (Septiembre de 2010)
-
07/10/2009 | BORME act no.: 601545 | Register: ALICANTEDepósito de cuentas anuales (Septiembre de 2009)
-
10/07/2009 | BORME act no.: 309020 | Register: ALICANTEAmpliación de capital
-
10/09/2008 | BORME act no.: 424387 | Register: ALICANTEConstitución
-
10/09/2008 | BORME act no.: 424387 | Register: ALICANTENombramientos
Other information
The CIF of BIOARRAY SL is B54363049 and its business status is active. Its economic activity belongs to the CNAE 8690 - Other health activities. Its SIC is 8099 - Servicios sanitarios y similares.
BIOARRAY SL has Between 10 and 49 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Alicante. It has a total of 3 registration charges. Its latest announcement in Borme was published on 08/01/2020 and its last deposit of ordinary annual accounts is from the year 2023.
You can check the contact details of BIOARRAY SL such as phone number, address, or website in the Company Data module.
For more information about BIOARRAY SL, you can acquire one of our available financial reports, the Annual Accounts of the company, or check its payment incidents in the RAI delinquency file.
All the financial, business, and legal information we provide about BIOARRAY SL comes from official sources and is updated daily.
Do you want to know more about BIOARRAY SL??
Find out more about this company by consulting these reports: